Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Schizophrenia Research
|
December 14, 2023
EEG microstate D as psychosis-specific correlate in adolescents and young adults with clinical high risk for psychosis and first-episode psychosis
Matthias Liebrand, Angelos Katsarakis, Johannes Josi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 18, 2011
Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association study
Alexandra Schosser, Monika Schloegelhofer, Karoline Fuchs, et al.
Schizophrenia Bulletin
|
December 16, 2023
Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning
Thomas W Weickert, Ellen Ji, Cherrie Galletly, et al.
Schizophrenia Bulletin
|
February 28, 2012
Neurophysiological studies of auditory verbal hallucinations
Judith M Ford, Thomas Dierks, Derek J Fisher, et al.
Frontiers in Psychiatry
|
August 4, 2023
Case report: Psychosis and catatonia in an adolescent patient with adipsic hypernatremia and autoantibodies against the subfornical organ
Matthias Liebrand, Michael Rebsamen, Akari Nakamura-Utsunomiya, et al.
Nordic Journal of Psychiatry
|
November 5, 2010
No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders
Jochen Kindler, Ursula Bailer, Martina de Zwaan, et al.
Molecular Psychiatry
|
April 4, 2019
Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Jochen Kindler, Chai K Lim, Cynthia Shannon Weickert, et al.
Brain, Behavior, and Immunity
|
October 17, 2023
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial
Thomas W Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Addictive Behaviors
|
July 31, 2021
Excessive and pathological Internet use - Risk-behavior or psychopathology?
Michael Kaess, Johanna Klar, Jochen Kindler, et al.
Schizophrenia Bulletin
|
June 18, 2014
Symptom dimensions of the psychotic symptom rating scales in psychosis: a multisite study
Todd S Woodward, Kwanghee Jung, Heungsun Hwang, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Schizophrenia Research
|
December 14, 2023
EEG microstate D as psychosis-specific correlate in adolescents and young adults with clinical high risk for psychosis and first-episode psychosis
Matthias Liebrand, Angelos Katsarakis, Johannes Josi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 18, 2011
Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association study
Alexandra Schosser, Monika Schloegelhofer, Karoline Fuchs, et al.
Schizophrenia Bulletin
|
December 16, 2023
Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning
Thomas W Weickert, Ellen Ji, Cherrie Galletly, et al.
Schizophrenia Bulletin
|
February 28, 2012
Neurophysiological studies of auditory verbal hallucinations
Judith M Ford, Thomas Dierks, Derek J Fisher, et al.
Frontiers in Psychiatry
|
August 4, 2023
Case report: Psychosis and catatonia in an adolescent patient with adipsic hypernatremia and autoantibodies against the subfornical organ
Matthias Liebrand, Michael Rebsamen, Akari Nakamura-Utsunomiya, et al.
Nordic Journal of Psychiatry
|
November 5, 2010
No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders
Jochen Kindler, Ursula Bailer, Martina de Zwaan, et al.
Molecular Psychiatry
|
April 4, 2019
Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Jochen Kindler, Chai K Lim, Cynthia Shannon Weickert, et al.
Brain, Behavior, and Immunity
|
October 17, 2023
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial
Thomas W Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Addictive Behaviors
|
July 31, 2021
Excessive and pathological Internet use - Risk-behavior or psychopathology?
Michael Kaess, Johanna Klar, Jochen Kindler, et al.
Schizophrenia Bulletin
|
June 18, 2014
Symptom dimensions of the psychotic symptom rating scales in psychosis: a multisite study
Todd S Woodward, Kwanghee Jung, Heungsun Hwang, et al.
Page
of 7